Literature DB >> 3890057

Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

E M Sternberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3890057     DOI: 10.1007/bf02918588

Source DB:  PubMed          Journal:  Surv Immunol Res        ISSN: 0252-9564


× No keyword cloud information.
  92 in total

1.  Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed.

Authors:  W L Norton; E R Hurd; D C Lewis; M Ziff
Journal:  J Lab Clin Med       Date:  1968-06

2.  A fibroblast mitogen present in scleroderma but not control sera: inhibition by proteinase inhibitors.

Authors:  E C LeRoy; M B Kahaleh; S Mercurio
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

3.  Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain.

Authors:  D D Wagner; V J Marder
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

4.  Autologous and allogeneic mixed lymphocyte reactions in progressive systemic sclerosis.

Authors:  J H Morse; B S Bodi
Journal:  Arthritis Rheum       Date:  1982-04

5.  Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis.

Authors:  J M Stuart; A E Postlethwaite; A H Kang
Journal:  J Lab Clin Med       Date:  1976-10

6.  Antibodies to collagen in scleroderma.

Authors:  A M Mackel; F DeLustro; F E Harper; E C LeRoy
Journal:  Arthritis Rheum       Date:  1982-05

7.  Characterization of the release of human monocyte regulators of fibroblast proliferation.

Authors:  F DeLustro; E C LeRoy
Journal:  J Reticuloendothel Soc       Date:  1982-04

8.  Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.

Authors:  M B Kahaleh; I Osborn; E C LeRoy
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

9.  Immune complexes in progressive systemic sclerosis (scleroderma).

Authors:  J R Seibold; T A Medsger; A Winkelstein; R H Kelly; G P Rodnan
Journal:  Arthritis Rheum       Date:  1982-10

10.  Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment.

Authors:  A E Postlethwaite; J Keski-Oja; G Balian; A H Kang
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  4 in total

Review 1.  How useful are serum autoantibodies in the diagnosis and prognosis of systemic sclerosis?

Authors:  O Meyer
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis.

Authors:  R Gustafsson; T H Tötterman; L Klareskog; R Hällgren
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

Review 3.  Mast cells, fibroblasts, and fibrosis. New clues to the riddle of mast cells.

Authors:  K L Choi; H N Claman
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Polymorphonuclear neutrophil function in systemic sclerosis.

Authors:  L Czirják; K Dankó; S Sipka; M Zeher; G Szegedi
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.